|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,824.50 GBX | +0.19% |
|
+1.08% | +35.50% |
| 12-12 | US FDA approves Innoviva's oral antibiotic for gonorrhea | RE |
| 12-12 | Surprise UK GDP Contraction Keeps FTSE 100 in the Red | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK PLC | Other Pharmaceuticals | +0.19% | +1.08% | +35.50% | +37.23% | +3.28% | 97.84B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- GSK Stock
- Charts GSK plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition